Patent · US Active

Stable formulations of a hyaluronan-degrading enzyme

US9993529B2 · kind B2 · utility

2Cited by

135References

55Claims

0Family size

Assignee

HALOZYME, INC. · US

Inventors

Tzung-Horng Yang · Del Mar, US
Daniel Vaughn · Encinitas, US
Michael James Labarre · San Diego, US
Christopher L. Caster · Del Mar, US
Francois Nicol · Carlsbad, US
Donghyun Kim · Shinagawa, JP

Key dates

Filing date	Jun 15, 2012
Grant date	Jun 12, 2018
Priority date	—
Expiry date	Jun 15, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y302/01035
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are compositions that are stable formulations of a hyaluronan-degrading enzyme or are stable co-formulations of a fast-acting insulin and a hyaluronan degrading enzyme, including a recombinant human PH20 (rHuPH20).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.